SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: ERENUMAB (AIMOVIG), BACLOFENO (LIORESAL INTRATECAL), OCTEOTRIDO IM (SANDOSTATIN LAR), EVEROLIMUS INMUNOSUPRESOR (CERTICAN), RIBOCICLIB (KISQALI) Y LAPATINIB (TYVERB).

Contract type	Supplies
CPV	33600000
Awarded to	Novartis Farmacéutica, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.